Dis-Chem Pharmacies (DCP) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Dis-Chem Pharmacies (JSE:DCP), currently being evaluated. In 2026, Dis-Chem Pharmacies generated $42.83 Billion in revenue and $1.21 Billion in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Dis-Chem Pharmacies is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2026): $42.83 Billion
- Free Cash Flow (2026): $1.21 Billion
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.